TSTL.L

Tristel Plc
Tristel PLC - Director/PDMR Shareholding
20th September 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9557E
Tristel PLC
20 September 2024
 

 

Tristel plc

("Tristel" or the "Company")

 

Director/PDMR Shareholding

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Liz Dixon, Chief Financial Officer of the Company, sold 50,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 397.5 pence per Ordinary Share.

 

As a result, Liz Dixon's beneficial interest in the Company is 150,000 Ordinary Shares, representing 0.31 per cent. of the total issued share capital.

 

For further information please contact:     

 

 

Tristel plc

Via Walbrook PR

Matt Sassone, Chief Executive Officer

www.investors.tristel.com

Liz Dixon, Chief Financial Officer


 


Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Charlotte Edgar

Mob: 07584 391 303



Cavendish Capital Markets Limited

Tel: 020 7220 0500

Geoff Nash/ Camilla Hume / Trisyia Jamaludin (Corporate Finance)


Sunila de Silva (Corporate Broking)

Louise Talbot (Sales)


 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Elizabeth Dixon

2.               

Reason for the Notification.        

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.   

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary Shares

Identification code

GB00B07RVT99

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price

Volume(s)

397.5 pence

50,000

 

 

 

 

d)

Aggregated information:

       -     Aggregated volume

       -     Aggregated price

 

 

 

Single transaction as in 4 c) above

e)

Date of the transaction

19 September 2024

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGMLRLMGDZM]]>
TwitterFacebookLinkedIn